
Trump Administration Executive Order (EO) Tracker
Warren H. Maruyama
Senior Counsel Global Regulatory
Languages
English
Warren served as General Counsel of the Office of the United States Trade Representative (USTR) for President George W. Bush from 2007-2009, Associate Director of the White House Policy Development staff for President George H.W. Bush (1989-1992), and USTR Associate General Counsel (1983-1989). He started his career in the federal government as a staff lawyer at the U.S. International Trade Commission.
Warren is recognized for his strategic vision, creativity, and innovative and effective solutions to trade challenges. As USTR General Counsel, he oversaw the filing of 10 U.S. WTO and bilateral challenges to foreign trade barriers, including 5 cases against China; helped lead Doha, Uruguay Round, and FTA negotiations; supervised the U.S. Section 301 carousel retaliation list in the WTO Beef-Hormones dispute; and oversaw USTR's participation in the U.S.-China SED and JCCT Cabinet-level Dialogues. He served as one of USTR’s lead negotiators for the "May 10" agreement between the Bush 43 Administration and House Democratic Leadership that resolved a decade-long impasse over the role of labor and environmental rules in U.S. FTAs, and cleared the way for Congressional approval of the Peru, Korea, Colombia, and Panama FTAs. As a White House staffer, he helped design President George H.W. Bush’s Steel Trade Liberalization, Super 301, and Enterprise for the Americas Initiatives, and drafted the President’s announcement of the successful conclusion of NAFTA negotiations.
Advised Her Majesty’s Treasury on New Zealand and Australia FTA negotiations regarding financial services and investment and provided virtual online training to the negotiating team.
Advised PhRMA during the negotiation of new chapters in U.S.-Australia and U.S.-Korea FTAs regarding rules for pharmaceutical price controls.
Secured major breakthrough for U.S. insurance as part of U.S.-Japan "confidence-building agreement" in TPP.
Represented U.S. steel-consuming manufacturers in opposing Section 201 steel import safeguards and securing their early termination by the Bush 43 Administration in December 2003.
Led U.S. negotiating team during Doha Round antidumping negotiations, including provisions upholding “zeroing” in Chairman’s draft.
Handled successful selection, preparation, litigation, and defense of WTO, U.S.-Canada FTA, and GATT disputes.
Advised Business Coalition for U.S.-China Trade during China’s WTO accession negotiations and PNTR votes.
Advised National Council of La Raza pro bono during NAFTA regarding successful establishment of North American Development Bank as part of implementing bill.
Worked with USTR and USDA to negotiate solutions to Chinese antidumping investigations of sorghum and dried distillers grains and Colombian CVD investigation of U.S. ethanol.
Secured product exclusions from Section 301 tariffs from Trump 1.0 Administration for medical device, seed, and semiconductor products during Trump 1.0